ATA361576A - Verfahren zur herstellung von neuen, substi- tuierten 4-methyl-5-imidazolyl- und 2-thia- zolylguanidinen - Google Patents

Verfahren zur herstellung von neuen, substi- tuierten 4-methyl-5-imidazolyl- und 2-thia- zolylguanidinen

Info

Publication number
ATA361576A
ATA361576A AT361576A AT361576A ATA361576A AT A361576 A ATA361576 A AT A361576A AT 361576 A AT361576 A AT 361576A AT 361576 A AT361576 A AT 361576A AT A361576 A ATA361576 A AT A361576A
Authority
AT
Austria
Prior art keywords
guanidines
thiazolyl
imidazolyl
substituted
methyl
Prior art date
Application number
AT361576A
Other languages
English (en)
Other versions
AT356131B (de
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB21817/75A external-priority patent/GB1553070A/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Priority to AT0507879A priority Critical patent/ATA507879A/de
Publication of ATA361576A publication Critical patent/ATA361576A/de
Application granted granted Critical
Publication of AT356131B publication Critical patent/AT356131B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/26—Radicals substituted by sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT361576A 1975-05-21 1976-05-18 Verfahren zur herstellung von neuen, substi- tuierten 4-methyl-5-imidazolyl- und 2-thia- zolylguanidinen AT356131B (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT0507879A ATA507879A (de) 1975-05-21 1979-07-23 Verfahren zur herstellung von neuen, substituierten 4-methyl-5-amidazolyl- und

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB21817/75A GB1553070A (en) 1975-05-21 1975-05-21 Thiourea guanidine and 1-nitro-2,2-diaminoethylene derivatives
GB4778275 1975-11-20

Publications (2)

Publication Number Publication Date
ATA361576A true ATA361576A (de) 1979-09-15
AT356131B AT356131B (de) 1980-04-10

Family

ID=26255540

Family Applications (1)

Application Number Title Priority Date Filing Date
AT361576A AT356131B (de) 1975-05-21 1976-05-18 Verfahren zur herstellung von neuen, substi- tuierten 4-methyl-5-imidazolyl- und 2-thia- zolylguanidinen

Country Status (13)

Country Link
US (6) US4098898A (de)
JP (1) JPS51141865A (de)
AT (1) AT356131B (de)
AU (1) AU503525B2 (de)
CA (1) CA1076581A (de)
CH (2) CH626883A5 (de)
DE (1) DE2621834A1 (de)
DK (1) DK145541C (de)
FR (1) FR2311536A1 (de)
IE (1) IE44062B1 (de)
IL (1) IL49528A (de)
NL (1) NL7605405A (de)
SE (1) SE419544B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4170652A (en) * 1974-03-12 1979-10-09 Smith Kline & French Laboratories Limited Heterocyclic-methylthioalkyl-guanidines
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
US4200760A (en) * 1978-09-26 1980-04-29 Bristol-Myers Company Imidazolylalkylthioalkylamino-ethylene derivatives
EP0010893B1 (de) * 1978-10-16 1984-02-08 Imperial Chemical Industries Plc Verzweigtkettige heterozyklische Guanidinderivate mit antisekretorischer Wirkung, Verfahren zu ihrer Herstellung, Zwischenprodukte und die genannten Derivate enthaltende pharmazeutische Zusammensetzungen
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
JPS568357A (en) * 1979-02-16 1981-01-28 Eisai Co Ltd Cyanoguanidine derivative and its production
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4315024A (en) * 1980-08-08 1982-02-09 Cooper Laboratories, Inc. Compositions and method for treating red eye
US4382090A (en) * 1980-10-02 1983-05-03 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds
US4443456A (en) * 1981-05-12 1984-04-17 William H. Rorer, Inc. Pyridyl alkylene amidinoureas
US4810717A (en) * 1981-11-12 1989-03-07 E. I. Du Pont De Nemours And Company 2-hydroxypropylamine aryl ester derivatives
DE3232462A1 (de) * 1982-09-01 1984-03-01 Bayer Ag, 5090 Leverkusen 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4795719A (en) * 1984-05-15 1989-01-03 Waferscale Integration, Inc. Self-aligned split gate eprom process
EP0199845B1 (de) * 1985-04-02 1990-08-01 HEUMANN PHARMA GMBH & CO Imidazolylalkylguanidinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
NL8601585A (nl) * 1986-06-19 1988-01-18 Vereniging Voor Christelijk Wetenschappelijk Onderwijs N-(2-gesubstitueerde alkyl)-n-imidazol-4-yl alkyl guanidine.
DE3631334A1 (de) * 1986-09-15 1988-03-17 Heumann Pharma Gmbh & Co Neue imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4996221A (en) * 1987-01-13 1991-02-26 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives as immune modulators
US5145860A (en) * 1989-01-05 1992-09-08 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds and pharmaceutical composition comprising the same
US5229386A (en) * 1989-01-05 1993-07-20 Fujisawa Pharmaceutical Co., Ltd. Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0573542B1 (de) * 1991-02-27 1997-10-15 Seed Capital Investments( Sci) B.V. Imidazol-derivate mit antagonistischer aktivität auf den histamin-h3-receptor
NL9100365A (nl) * 1991-02-27 1992-09-16 Seed Capital Investments Imidazoolderivaten met agonistische of antagonistische activiteit op de histamine h3-receptor.
WO1993014753A1 (en) * 1992-01-27 1993-08-05 The Board Of Trustees Of The Leland Stanford Junior University Histamine derivatives and methods for their use
US5808090A (en) * 1996-02-22 1998-09-15 Endo Pharmaceuticals Inc. Process for preventing precipitation in cimetidine injection solutions
WO2000016766A1 (en) * 1998-09-22 2000-03-30 Ishihara Sangyo Kaisha Ltd. Medical composition containing nitroetheneamine derivative or salt thereof as active constituent
GB0404434D0 (en) 2004-02-27 2004-03-31 Novartis Ag Organic compounds
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1305549A (de) * 1969-10-29 1973-02-07
US3868457A (en) * 1969-10-29 1975-02-25 Smith Kline French Lab Method of inhibiting histamine activity with guanidine compounds
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3808336A (en) * 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
US4000302A (en) * 1972-04-20 1976-12-28 Smith Kline & French Laboratories Limited Pharmaceutical compositions and methods of inhibiting H-1 and H-2 histamine receptors
US4000296A (en) * 1972-09-05 1976-12-28 Smith Kline & French Laboratories Limited Imidazole alkylguanidine compounds
US3979398A (en) * 1973-02-08 1976-09-07 Smith Kline & French Laboratories Limited Sulphoxides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4046907A (en) * 1973-05-17 1977-09-06 Smith Kline & French Laboratories Limited Imidazole alkylaminoethylene compounds
US4124717A (en) * 1973-05-17 1978-11-07 Smith Kline & French Laboratories Limited Thiazolyl alkylaminoethylene compounds
GB1431589A (en) * 1973-07-13 1976-04-07 Smith Kline French Lab Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups
US4152443A (en) * 1973-07-13 1979-05-01 Smith Kline & French Laboratories Limited Imidazolyl thioureas, ureas and guanidines
GB1493931A (en) * 1974-02-07 1977-11-30 Smith Kline French Lab Guanidines isothioureas and thioureas
US4118496A (en) * 1974-03-12 1978-10-03 Smith Kline & French Laboratories Limited Heterocyclic-methylthioalkyl-amidines
US4013769A (en) * 1974-05-09 1977-03-22 Smith Kline & French Laboratories Limited Pyridyl-alkylaminoethylene compounds
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
US4093621A (en) * 1974-09-02 1978-06-06 Smith Kline & French Laboratories Limited Process for preparing heterocyclicalkylthioalkyl-N-cyanoguanidines and thioureas
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4154838A (en) * 1975-07-31 1979-05-15 Smith Kline & French Laboratories Limited Alkoxy pyridine
IE47044B1 (en) * 1977-04-20 1983-12-14 Ici Ltd Guanidine derivatives
US4165378A (en) * 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles

Also Published As

Publication number Publication date
AU503525B2 (en) 1979-09-06
US4440775A (en) 1984-04-03
IE44062L (en) 1976-11-21
FR2311536B1 (de) 1979-03-23
US4098898A (en) 1978-07-04
IL49528A0 (en) 1976-07-30
DE2621834A1 (de) 1976-12-02
AU1419576A (en) 1977-11-24
DK145541C (da) 1983-05-16
SE7605620L (sv) 1976-11-22
AT356131B (de) 1980-04-10
US4347250A (en) 1982-08-31
CH626883A5 (de) 1981-12-15
IE44062B1 (en) 1981-08-12
US4276301A (en) 1981-06-30
FR2311536A1 (fr) 1976-12-17
US4247558A (en) 1981-01-27
CA1076581A (en) 1980-04-29
DK145541B (da) 1982-12-06
NL7605405A (nl) 1976-11-23
IL49528A (en) 1980-11-30
CH624941A5 (de) 1981-08-31
US4333946A (en) 1982-06-08
JPS51141865A (en) 1976-12-07
SE419544B (sv) 1981-08-10
DK206576A (da) 1976-11-22

Similar Documents

Publication Publication Date Title
ATA361576A (de) Verfahren zur herstellung von neuen, substi- tuierten 4-methyl-5-imidazolyl- und 2-thia- zolylguanidinen
AT353783B (de) Verfahren zur herstellung von neuen pyrrolidin- -2-on-derivaten
ATA348877A (de) Verfahren zur herstellung von neuen n- acylierten
AT349634B (de) Verfahren zur herstellung von neuen anthra- cyclinglycosiden
ATA65076A (de) Verfahren zur herstellung von neuen oxadiazolinon-derivaten
AT350197B (de) Verfahren zur herstellung von neuen ebur- nameninderivaten
ATA303477A (de) Verfahren zur herstellung von neuen indazolyl- (4-)-oxy-propanolaminen
AT343095B (de) Verfahren zur herstellung von neuen 2,6-dinitro-3-azido-4-trifluormethylanilinen und -hydrazinen
AT340408B (de) Verfahren zur herstellung von neuen 1-aryl-5-alkyliden-2,4-dioxo-imidazolidinen
AT342078B (de) Verfahren zur herstellung von neuen vinylthionophosphorsaureestern
AT351555B (de) Verfahren zur herstellung von neuen nitro- soharnstoff-derivaten
AT353411B (de) Verfahren zur herstellung von neuen 4- -dedimethylamino-4-arylsulfonamido-5a,6- -anhydrotetracyclinen
AT346351B (de) Verfahren zur herstellung von neuen oxadiazin- derivaten
AT353278B (de) Verfahren zur herstellung von neuen azetidin- derivaten
AT343682B (de) Verfahren zur herstellung von neuen o-pyrazolopyrimidinthionothiolphosphorsaureestern
AT352714B (de) Verfahren zur herstellung von neuen nitroimi- dazolylvinylthiadiazolen
AT351163B (de) Verfahren zur herstellung von neuen cephalos- porinen
AT342555B (de) Verfahren zur herstellung von neuen 2-methyl-3-buten-3-halogen-2-olen
AT346354B (de) Verfahren zur herstellung von neuen 2- morpholinonderivaten
AT351558B (de) Verfahren zur herstellung von neuen 2-formyl- amino-phenylguanidinen
ATA195578A (de) Verfahren zur herstellung von neuen 2- piperidinoalkyl-(1-benzofuranen, 1,4-benzo- dioxanen oder 1, 4-benzoxathianen)
ATA257477A (de) Verfahren zur herstellung von neuen 1-methyl-3-alkyl -7- oxoalkylxanthinen
AT348529B (de) Verfahren zur herstellung von neuen naphthyridinderivaten
AT351044B (de) Verfahren zur herstellung von neuen azetidin- derivaten
AT348998B (de) Verfahren zur herstellung von neuen (1- (4-cyclohexylphenyl)-aethylthio-, -sulfinyl- und -sulfonyl)-essigsaeure-derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
ELJ Ceased due to non-payment of the annual fee